Recipharm appoints Henrik Stenqvist as new Chief Financial Officer
Henrik Stenqvist brings 24 years’ finance and management experience to Recipharm. Prior to joining Recipharm he served as CFO of the Meda Group and held other leading finance positions in the pharmaceutical industry. He holds a degree in Finance and Business Administration from the University of Linköping, Sweden.
Thomas Eldered says “I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path.”
Henrik Stenqvist says "I'm looking forward to contributing to the continued success of Recipharm in my new capacity as Chief Financial Officer of this leading company."
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.